BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33373722)

  • 1. Immune Checkpoint Inhibitor Myocarditis With Normal Cardiac Magnetic Resonance Imaging: Importance of Cardiac Biopsy and Early Diagnosis.
    Ederhy S; Fenioux C; Cholet C; Rouvier P; Redheuil A; Cohen A; Salem JE
    Can J Cardiol; 2021 Oct; 37(10):1654-1656. PubMed ID: 33373722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitor-mediated myasthenia gravis with focal subclinical myocarditis progressing to symptomatic cardiac disease.
    Leaver PJ; Jang HS; Vernon ST; Fernando SL
    BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32404371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.
    Peleg Hasson S; Salwen B; Sivan A; Shamai S; Geva R; Merimsky O; Raphael A; Shmilovich H; Moshkovits Y; Kapusta L; Rozenbaum Z; Wolf I; Laufer-Perl M
    Clin Res Cardiol; 2021 Jan; 110(1):50-60. PubMed ID: 32296970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.
    Delombaerde D; Vervloet D; Berwouts D; Beckers R; Prenen H; Peeters M; Gremonprez F; Croes L; Vulsteke C
    J Med Case Rep; 2022 Jul; 16(1):275. PubMed ID: 35831829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
    Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
    Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic Myocarditis with Mild Cardiac Marker Elevation Following Nivolumab-Induced Myositis.
    Shindo A; Yamasaki M; Uchino K; Yamasaki M
    Int Heart J; 2022; 63(1):180-183. PubMed ID: 35095069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtle-but-smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits.
    Ida M; Nakamori S; Yamamoto S; Watanabe S; Imanaka-Yoshida K; Ishida M; Sakuma H; Yamanaka K; Dohi K
    ESC Heart Fail; 2022 Jun; 9(3):2027-2031. PubMed ID: 35352879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review.
    Lehmann LH; Cautela J; Palaskas N; Baik AH; Meijers WC; Allenbach Y; Alexandre J; Rassaf T; Müller OJ; Aras M; Asnani AH; Deswal A; Laufer-Perl M; Thuny F; Kerneis M; Hayek SS; Ederhy S; Salem JE; Moslehi JJ
    JAMA Cardiol; 2021 Nov; 6(11):1329-1337. PubMed ID: 34232253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor Therapy.
    Giblin GT; Dennehy C; Featherstone H; Clarke R; Murphy L; Timlin D; O'Keane C; Mulligan N; Kelly CM; Joyce E
    Circ Heart Fail; 2021 Feb; 14(2):e007524. PubMed ID: 33478241
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute Myocarditis by Immune Checkpoint Inhibitor Identified by Quantitative Pixel-Wise Analysis of Native T1 Mapping.
    Kato S; Fukui K; Kodama S; Azuma M; Nakayama N; Kishimoto M; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
    Circ Cardiovasc Imaging; 2021 May; 14(5):e012177. PubMed ID: 33951932
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring of the Evolution of Immune Checkpoint Inhibitor Myocarditis With Cardiovascular Magnetic Resonance.
    Sato T; Nakamori S; Watanabe S; Nishikawa K; Inoue T; Imanaka-Yoshida K; Ishida M; Sakuma H; Ito M; Dohi K
    Circ Cardiovasc Imaging; 2020 Nov; 13(11):e010633. PubMed ID: 33153280
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
    Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
    J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
    Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
    Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of patients presenting with life-threatening ventricular arrhythmias and suspected myocarditis: The key role of endomyocardial biopsy.
    Narducci ML; La Rosa G; Pinnacchio G; Inzani F; d'Amati G; Perna F; Bencardino G; D'Amario D; Pieroni M; Dello Russo A; Casella M; Pelargonio G; Crea F
    Heart Rhythm; 2021 Jun; 18(6):907-915. PubMed ID: 33516948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy.
    Palaskas NL; Segura A; Lelenwa L; Siddiqui BA; Subudhi SK; Lopez-Mattei J; Durand JB; Deswal A; Zhao B; Maximilian Buja L; Iliescu C
    Eur J Heart Fail; 2021 Oct; 23(10):1725-1735. PubMed ID: 34114291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to approach the great mimic? Improving techniques for the diagnosis of myocarditis.
    Mavrogeni S; Markousis-Mavrogenis G; Kolovou G
    Expert Rev Cardiovasc Ther; 2016; 14(1):105-15. PubMed ID: 26559548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor-induced Myocarditis.
    Cadour F; Cautela J; Rapacchi S; Varoquaux A; Habert P; Arnaud F; Jacquier A; Meilhac A; Paganelli F; Lalevée N; Scemama U; Thuny F
    Radiology; 2022 Jun; 303(3):512-521. PubMed ID: 35230185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels.
    Scard C; Nguyen JM; Varey E; Moustaghfir I; Khammari A; Dreno B
    Eur J Dermatol; 2021 Apr; 31(2):205-212. PubMed ID: 33814359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute fulminant necrotizing eosinophilic myocarditis: early diagnosis and treatment.
    Callan PD; Baltabaeva A; Kamal M; Wong J; Lane R; Robertus JL; Banner NR
    ESC Heart Fail; 2017 Nov; 4(4):660-664. PubMed ID: 29154424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.